CLINICAL TRIALS

Over the years, Heart Lung Centre has connected hundreds of people to clinical trials. By bringing study participants and clinical research staff together, we are able to revolutionise the study participant recruitment process in order to make it quicker, accurate, and more personalised than ever - all while maintaining your privacy.

REGISTER NOW

You can have a role in research that could change medicine forever.

Paid clinical research studies are being conducted at Heart Lung Centre to learn more about investigational medications that are not yet available to the public.

Are Clinical Trials safe?

This is a very important question. At Heart Lung Centre, all our trials are reviewed by an independent Research Ethics Committee, who ensure that our trials are as safe as possible. We are here to answer any questions.

 

Learn More

Do I get paid?

Our trials vary greatly in terms of time spent on the unit and the number of procedures performed. Once we have identified a suitable trial, we can inform you of the potential compensation for your participation.

 

Learn More

What facilities are there?

Whether you’re here for an hour or the whole day, we will endeavour to make your stay as comfortable as possible. The volunteer lounge will provide you with a space to pass the time pleasantly between assessments.

 

Why do you offer Clinical Trials?

Before a medication or new device for treatment of medical issues is available to the public, the Food and Drug Administration (FDA) must review and approve the medication or device for public use. The FDA does this to learn more about the product and make sure that it is effective and safe.

To get FDA approval, the company that makes the medication or device is required to conduct clinical research studies.

The companies ask people to volunteer for clinical research studies. In these studies, volunteers are given the investigational medication or device and are evaluated by study doctors and staff members.

After clinical research studies are completed, the pharmaceutical company submits the study information to the FDA. The FDA reviews this information and decides if the investigational medication or device can become available to the public.

Explore current trials to check eligibility and register

  • Asthma studies​

    Asthma Clinical Trials are to evaluate newly developed medications and new combinations of well-established medications for the treatment of asthma.

    For all studies, participants are paid for their time, travel and any inconvenience.

    Medications administered, trial or placebo would be in addition to a volunteer’s current medication(s).

    If you would like to find out more register your interest and we will be in touch. Or contact us on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com

    Current studies are detailed below.

  • Asthma Study GA41003

    This is a clinical trial to evaluate a newly developed medication for the treatment of Asthma against a placebo. The medication has been tested in previous clinical trials with volunteers and no safety concerns were raised.

    Any medication administered, trial or placebo would be in addition to your current medication(s)

    To take part in this study you:

    • Must have been diagnosed with Asthma for 4 months or more
    • Must be between the ages of 18 to 65
    • Must use Preventative Asthma Medication on a stable, daily basis to manage your Asthma
    • Must be a non-smoker or an ex-smoker
    • Must Not be, pregnant, lactating or trying to conceive with your partner. (If applicable)
    • Must Not be currently enrolled another Clinical Trial

     

    This study involves up to 9 visits to our Central London Clinic over 14 weeks.  No over-night stays required.

    You will be paid up to £1600 (pro rata) for your time, and any inconvenience.  Reasonable travel expenses will be reimbursed.

    If you believe you may eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com

    Even if you do not believe you may be eligible, do register your interest as new opportunities are pending.

    REGISTER
  • Asthma Study SELK2-1

    This is a clinical trial to evaluate a newly developed antibody medication for the treatment of Asthma against a placebo. The medication has been tested in previous clinical trials with volunteers, the medication was well tolerated and no safety concerns were raised.

    Any medication administered, trial or placebo would be in addition to your current medication(s)

    To take part in this study you:

    • Must have been diagnosed with Asthma for 4 months or more
    • Must be between the ages of 18 to 65.
    • Must use rescue asthma medication as and when required to manage your Asthma
    • Must be a non-smoker or an ex-smoker
    • Must Not be pregnant, lactating or trying to conceive with your partner. (If applicable)
    • Must Not be currently enrolled another Clinical Trial

     

    This study involves up to 15 visits to our central London clinic over 14 weeks. No over-night stays required.

    You will be paid up to £2800 (pro rata) for your time, and any inconvenience.

    If you believe you may eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com

    Even if you do not believe you may be eligible, do register your interest as new opportunities are pending.

    REGISTER
  • Asthma Study D3250C00059

    This is a clinical trial to evaluate a newly developed anti-inflammatory medication for the treatment of Asthma against a placebo. The medication has been tested in previous clinical trials with volunteers with severe Asthma, no safety issues were reported and the medication was shown to significantly reduce exacerbation rates, improve lung function and symptoms.

    Any medication administered, trial or placebo would be in addition to your current medication(s).

    To take part in this study you:

    • Must have been diagnosed with Asthma for 12 months or more
    • Must be between the ages of 18 to 70
    • Must use preventative Asthma medication on a stable, daily basis to manage your Asthma
    • Must be a non-smoker or an ex-smoker
    • Must Not be, pregnant, lactating or trying to conceive with your partner. (If applicable)
    • Must Not be currently enrolled another Clinical Trial

     

    This study involves 11 to 13 visits to our central London clinic over 58 weeks. No over-night stays required.

    You will be paid up to £1650 (pro rata) for your time, and any inconvenience. Reasonable travel expenses will be reimbursed.

    If you believe you may eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com

    Even if you do not believe you may be eligible, do register your interest as new opportunities are pending.

    REGISTER
  • COPD studies​

    Chronic Obstructive Pulmonary Disease Clinical Trials are to evaluate newly developed medications and new combinations of well-established medications for the treatment of COPD.

    For all studies, participants are paid for their time, travel and any inconvenience.

    Medications administered, trial or placebo would be in addition to a volunteer’s current medication(s).

    If you believe you may eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com

    Current studies are detailed below.

  • COPD Study IONIS

    This is a clinical trial to evaluate a newly developed medication for the treatment of COPD against a placebo. The medication has been tested in previous clinical trials with volunteers and no safety issue were reported and the medication was well tolerated.

    Any medication administered, trial or placebo would be in addition to your current medication(s).

    To take part in this study you:

    • Must have been diagnosed with Chronic Obstructive Pulmonary Disease / COPD for 4 months or more
    • Must be between the ages of 40 and 70
    • Must be a smoker or an ex-smoker
    • Must Not be using supplemental Oxygen, even on an occasional basis
    • Must Not have a history within the past 5 years of life-threatening COPD exacerbations including intensive care and or intubation
    • Must Not be currently enrolled another clinical trial

     

    This study involves 11 to 12 visits to our central London clinic over 27 weeks. No over-night stays required.

    You will be paid up to £1600 (pro rata) for your time, and any inconvenience. Reasonable travel expenses will be reimbursed.

    If you believe you may eligible to take part and would like to find out more, register your interest and we will be in touch. Or contact us to find out more on 0207 034 3341 or 0800 023 4824 or recruitment@heartlungcentre.com

    Even if you do not believe you may be eligible, do register your interest as new opportunities are pending.

    REGISTER

FAQ'S

If you want to know more about clinical trials or are considering participating in one, the following frequently asked questions describe the role of a patient and will help you understand this unique research program.

FAQ'S

Location

Explore beyond the Heart Lung Centre and discover Respiratory Clinical Trials and our hospital Queen Anne Street Medical Centre. Our state of the art facility offers a range of medical services, including consultants in different specialties, diagnostic tests and an operating theatre.

20 Queen Anne Street,
London, W1G 8HU

E: recruitment@heartlungcentre.com
P: 0800 023 4824
P: 0207 0343301

Give us a call or email us, we endeavour to answer all enquiries within 24 hours on business days.

We are open from 9am — 5pm week days.